Year in review 2012: Critical Care - cardiology

A very important trial challenged the use of intra-aortic balloon pump (IABP) counterpulsation [3]. In this randomized trial including 600 patients with cardiogenic shock complicating acute myocardial infarction, IABP failed to improve mortality at 30 days (40% versus 41%, P = 0.69). There were no significant differences in the time to hemodynamic stabilization, including blood lactate levels, and this was not affected by the dose and duration of catecholamine therapy. Surprisingly, the rate of complications did not differ either, including bleeding and ischemic events. It should be highlighted that this trial included patients for whom an early revascularization strategy was planned, which may explain, at least in part, the relatively low mortality in both groups. These results may not apply in other types of cardiogenic shock.

A case control study evaluated the potential role of descending aortic calcifications on complications after use of IABP in cardiac surgery [4]. In a series of 459 patients after cardiac surgery, perioperative IABP and descending aortic atheroma were independently associated with perioperative kidney injury and in-hospital mortality.

Use of IABP is sometimes proposed as an adjunct to extracorporeal membrane oxygenation (ECMO) in order to preserve myocardial and cerebral perfusion. In an experimental model of prolonged cardiac arrest, the effects of IABP as well as ECMO cannulation site on cerebral and coronary perfusion were investigated [5]. Both femoro-femoral and femoro-subclavian ECMO provided adequate brain perfusion and oxygenation but femoro-femoral ECMO offered better coronary perfusion than femoro-subclavian ECMO. Addition of IABP to ECMO worsened coronary perfusion, especially in femoro-femoral ECMO. These experimental data do not support the adjunction of IABP to ECMO in cardiac arrest.

The measurement of blood lactate levels is commonly used to guide resuscitation in shock but lactate can be of variable origin. Early after admission, lactate is predominantly of anaerobic origin but rapidly other causes of hyperlactatemia may play a role. At the onset of shock, 69% of patients with cardiogenic shock and 76% of patients with septic shock presenting hyperlactatemia also had a high lactate to pyruvate ratio [6]. The time course of the lactate/pyruvate ratio decreased more slowly in non-survivors and in patients with cardiogenic shock than in the others. When lactate is not of anaerobic origin, it can arise either from aerobic causes, mostly accelerated glycolysis, or a decrease in lactate clearance. Lactate metabolism was investigated using muscle microdialysis, exogenous lactate infusion and stable isotopes in a series of healthy volunteers challenged with low dose endotoxin [7]. Plasma lactate concentration rapidly but modestly increased, never exceeding 2 mmol/l, in relation to the increase in resting energy expenditure. Muscle lactate production and total body lactate clearance remained constant. It is likely that immune cells may be an important source of lactate in sepsis. This is in agreement with previous data showing increased lactate production in white blood cells in sepsis [8].

Metformin can also lead to severe lactic acidosis associated with organ dysfunction. Metformin intoxication is associated with a decrease in oxygen consumption (VO2), related to mitochondrial toxicity [9]. To evaluate the extent to which acidosis itself may explain the impaired mitochondrial function, lactic acid was infused in a pig model to achieve the same increase in lactate levels and decrease in pH as in metformin intoxicated animals [10]. Oxygen delivery was similar in the two groups but VO2 markedly decreased in metformin intoxication whereas it slightly increased with lactic acid infusion. Unfortunately, glucose levels also markedly differed between the two groups, and this may have impacted energy expenditure. Compared to sham animals, mitochondrial activity was markedly impaired in metformin intoxication. A similar alteration in mitochondrial activity was also observed in platelets obtained from humans with metformin-related lactic acidosis [11]. These observations should not prevent physicians from using metformin, a drug that has been shown to have many useful effects when used appropriately. Of note, metformin administration may even attenuate ventilation-induced lung injury [12]. In a rabbit model of ventilation-induced lung injury, pre-treatment with metformin was associated with a reduction of lung edema and histologic lesions.

Carbon monoxide is an endogenous mediator with pleiotropic effects, including microvascular vasodilation, angiogenesis and cellular protection. Carbon monoxide production can be modulated in various directions in disease states. In a retrospective analysis of 868 patients admitted to a single ICU, carboxyhemoglobin levels were measured to evaluate endogenous carbon monoxide production [13]. Mean carboxyhemoglobin levels differed between admission categories, with the highest values observed in patients with renal and gastrointestinal disease and the lowest levels in neurological diseases. Patients who had higher severity scores on admission and non-survivors had lower minimal levels of carboxyhemoglobin during their stay in the ICU. These results indirectly suggest that endogenous carbon monoxide has a protective role.

Echocardiography may have a place in identifying cardiac origins of weaning failure [27–29]. In addition, echocardiography may further help to discriminate between a systolic and diastolic component of heart dysfunction, which may lead to different therapies. Transthoracic echocardiography with Doppler tissue imaging was applied just before and 10 minutes after initiation of weaning attempts in 68 patients [30]. Twenty patients failed to be weaned from mechanical ventilation and a cardiac cause contributed to this in 15 of these. LVEF, as an index of systolic function, did not differ among weaning success and weaning failure. On the contrary, displacement of mitral annulus identified by tissue Doppler was lower in patients failing to be weaned, suggesting that diastolic impairment contributed markedly to weaning failure.

Lung ultrasonography is applied more and more for the evaluation of lung disease. It was applied in 98 patients presenting to the emergency department for flu-like symptoms during the 2009 influenza A (H1N1) pandemic [31]. Lung ultrasonography had excellent diagnostic properties to detect lung infection (sensitivity 94%, specificity 85%, positive predictive value 87% and negative predictive value 93%). More importantly, lung ultrasonography was abnormal in 16 patients with initially normal chest X-ray who later were proven to effectively have viral or bacterial pneumonia. Another group of investigators used lung ultrasonography to identify bacterial pneumonia in patients with H1N1 viral infection [32]. Viral pneumonia was associated with diffuse B line patterns only whereas bacterial pneumonia was characterized by the presence of consolidated areas with aeric bronchogram, associated or not with diffuse B line patterns. Admittedly this approach was somewhat cumbersome and required careful evaluation of anterior, lateral and posterior parts of the chest.

The microcirculation is an area of continued interest. As alterations of microvascular perfusion in sepsis and their consequences are now recognized, new therapies are urgently needed. Enoxaparin acts not only as an anticoagulant but has marked anti-inflammatory properties. In rats, enoxaparin administration just after endotoxin administration, compared to placebo, better preserved endothelial function as reflected by a better preserved blood pressure and gut microvascular perfusion [33]. These results were further extended in a trial by another group of investigators demonstrating that enoxaparin decreased adhesion and rolling of white blood cells and, more importantly, decreased the severity of organ dysfunction in endotoxic rats [34].

Evaluation of endothelial function at the bedside can be done in several ways. Evaluation of brachial artery reactivity is one of these techniques. Flow and diameter of the vessels are evaluated with a high frequency vascular ultrasonic probe and vascular occlusion is performed with a cuff positioned on the same arm. Using this technique in 52 controls and 95 patients with severe sepsis, hyperemic velocity and flow-mediated dilation were found to be decreased in patients with sepsis [35]. Hyperemic velocity but not flow-mediated dilation was found to be associated with outcome. This test is simple and easy to reproduce at the bedside.

Acute kidney injury (AKI) is frequently observed after cardiac surgery, especially in patients with risk factors such as older age and diabetes. A preliminary trial suggested that bicarbonate administration could prevent post-operative AKI [36]. While confirmatory trials were on their way, some centers implemented this practice. In a before and after trial, administration of bicarbonate was not associated with reduction of AKI incidence [37]. If anything, bicarbonate administration was even associated with some detrimental effects, such as lower blood pressure and higher doses of vasopressor agents. These results were later confirmed by two randomized trials. In 92 patients with chronic kidney disease submitted to cardiac surgery, bicarbonate administration failed to prevent further deterioration of renal function [38]. A large scale multicenter randomized trial was stopped prematurely after inclusion of 350 patients for futility and potential harm [39]. More patients receiving bicarbonate developed AKI compared with control patients (48 versus 36%, P = 0.032 unadjusted, P = 0.120 after adjustment). Hospital mortality was increased in patients receiving sodium bicarbonate compared to control (6.3 versus 1.7%, P = 0.031). Altogether, these trials suggest that prophylactic use of sodium bicarbonate infusion to reduce the risk of AKI should be abandoned.

In patients with liver failure, the type of anticoagulation that should be applied during liver dialysis is still uncertain. Often liver dialysis is performed without anticoagulation but clotting of the system is frequent, decreasing its efficiency or even leading to paradoxical bleeding due to local consumption of the few available coagulation factors. Citrate anticoagulation is an attractive solution as it provides regional anticoagulation and does not have the bleeding risk of heparin. However, as citrate metabolism mostly occurs in liver and muscles there is a risk of citrate accumulation in these patients. Ten patients submitted to liver dialysis using the Molecular Adsorbents Recirculating System (MARS) were randomized in an open-label crossover trial of regional citrate anticoagulation versus anticoagulation-free liver dialysis [40]. None of the patients receiving citrate anticoagulation developed an event necessitating preterm cessation of MARS treatment. Four sessions without anticoagulation were interrupted preterm, one due to uncontrollable bleeding and three due to occlusive clotting of the extracorporeal blood circuit. There were no signs of citrate accumulation. Citrate anticoagulation may thus appear as a safe procedure for liver dialysis with MARS.

In conclusion, many studies published this year in the Journal have helped to increase our knowledge in these various fields.